Medison, the global biopharmaceutical company known for its unified commercialization platform that helps deliver breakthrough therapies to international markets, has announced the appointment of Francis Wan as Vice President and General Manager for Asia Pacific (APAC). He will also join Medison’s Global Leadership Team, reinforcing the company’s commitment to expanding its reach and accelerating access to innovative treatments across the region.
Francis will oversee Medison’s operations and strategic growth initiatives in the APAC region, one of the company’s most dynamic markets. With more than two decades of leadership experience in the biopharma industry, he has held senior roles such as President Asia Pacific at Biogen and Managing Director of Commercial Operations at MSD China. His extensive background in rare diseases, oncology, and healthcare access makes him well-positioned to strengthen Medison’s presence in Asia Pacific.
Commenting on his appointment, Francis Wan said he is driven by the goal of expanding access to advanced therapies in regions where many patients still struggle to receive life-changing treatments. He emphasized that Medison’s platform offers a powerful opportunity to close this gap. Having worked across multiple Asian healthcare systems, he highlighted the importance of creating sustainable access pathways that benefit both patients and healthcare providers, especially in rare and severe disease areas.
Health Technology Insights: Eleos Unveils Polaris AI Model for Post-Acute Care
Medison’s Founder and Executive Chairman, Meir Jakobsohn, said Francis’s leadership marks a key investment in the company’s long-term vision for the region. He noted that Asia Pacific represents both a challenge and an opportunity in terms of improving access to breakthrough therapies, aligning perfectly with Medison’s founding mission to ensure that every patient can benefit from innovation, regardless of geography.
CEO Gil Gurfinkel described Francis’s appointment as a major step forward in completing Medison’s global expansion roadmap. He stated that Francis’s deep understanding of healthcare systems across China and APAC, along with his ability to build strong commercial frameworks, will enhance Medison’s efforts to accelerate patient access and strengthen partnerships with biopharma innovators.
Victor Papamoniodis, Chief Commercial Officer at Medison, added that Francis brings exceptional experience in building and scaling operations across complex markets. His proven track record in driving commercial success will be vital to expanding Medison’s footprint and ensuring patients throughout Asia Pacific can benefit from transformative therapies.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 20 October 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
